Mostrar el registro sencillo del ítem

Systemic sclerosis overlap and non-overlap syndromes share clinical characteristics but differ in prognosis and treatments

dc.rights.licenseopenen_US
hal.structure.identifierImmunology from Concept and Experiments to Translation = Immunologie Conceptuelle, Expérimentale et Translationnelle [ImmunoConcept]
dc.contributor.authorSCHERLINGER, Marc
dc.contributor.authorLUTZ, J.
hal.structure.identifierImmunology from Concept and Experiments to Translation = Immunologie Conceptuelle, Expérimentale et Translationnelle [ImmunoConcept]
dc.contributor.authorGALLI, Gael
hal.structure.identifierImmunology from Concept and Experiments to Translation = Immunologie Conceptuelle, Expérimentale et Translationnelle [ImmunoConcept]
dc.contributor.authorRICHEZ, Christophe
dc.contributor.authorGOTTENBERG, J.-E.
dc.contributor.authorSIBILIA, J.
dc.contributor.authorARNAUD, L.
hal.structure.identifierImmunology from Concept and Experiments to Translation = Immunologie Conceptuelle, Expérimentale et Translationnelle [ImmunoConcept]
dc.contributor.authorBLANCO, Patrick
dc.contributor.authorSCHAEVERBEKE, T.
dc.contributor.authorCHATELUS, E.
hal.structure.identifierImmunology from Concept and Experiments to Translation = Immunologie Conceptuelle, Expérimentale et Translationnelle [ImmunoConcept]
dc.contributor.authorTRUCHETET, Marie Elise
dc.date.accessioned2022-11-15T09:30:47Z
dc.date.available2022-11-15T09:30:47Z
dc.date.issued2021-02
dc.identifier.issn0049-0172en_US
dc.identifier.otherhttps://doi.org/10.1016/j.semarthrit.2020.10.009en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/170261
dc.description.abstractEnObjectives : To screen for concomitant autoimmune disease in patients with systemic sclerosis (overlap SSc) and to describe their clinical characteristics and prognosis. Methods : This was a two-center retrospective observational study. Patients diagnosed with SSc according to the 2013 ACR-EULAR scleroderma classification criteria were screened for concomitant rheumatoid arthritis (RA), Sjögren syndrome (SgS) and systemic lupus erythematosus (SLE). Patient characteristics were retrieved from the medical records and were compared to those of a non-overlap SSc cohort. Results : Among the 534 SSc patients studied, thirty-four (6.4%) were identified as having overlap SSc. There were 21 (3.9%) patients with RA, 14 (2.6%) with SgS and 4 (0.7%) with SLE (5 patients had 2 AISD) . The disease phenotype of overlap SSc was similar to that of non-overlap SSc in terms of cutaneous phenotype, prevalence of pulmonary arterial hypertension, interstitial lung disease, digital ulcers and mortality. Using a multivariate Cox model, age (HR = 1.04, 95% CI [1.02–1.07]), the modified Rodnan skin score (HR = 1.08 per point, 95% CI [1.05–1.11]), and the presence of concomitant SgS (HR = 3.79, 95% CI [1.38–10.40]) were significantly associated with mortality. Overlap SSc were more likely to receive corticosteroids (85.3% vs. 45%, p < 0.001), immunosuppressive drugs (82.4% vs. 49.2%, p < 0.001) and biologics (52.9% vs. 3.8%, p < ZZ0.001). Conclusions : While overlap and non-overlap SSc shared common characteristics, patients with SgS/SSc had a higher risk of mortality, and those with RA/SSc received more corticosteroids, methotrexate and biologics. Screening for an associated AISD should be promoted since their co-occurrence with SSc may affect prognosis and treatments.
dc.language.isoENen_US
dc.subject.enAutoimmune disease
dc.subject.enRheumatoid arthritis
dc.subject.enSjogren's disease
dc.subject.enSystemic lupus erythematosus
dc.subject.enSystemic sclerosis
dc.title.enSystemic sclerosis overlap and non-overlap syndromes share clinical characteristics but differ in prognosis and treatments
dc.typeArticle de revueen_US
dc.identifier.doi10.1016/j.semarthrit.2020.10.009en_US
dc.subject.halSciences du Vivant [q-bio]/Immunologieen_US
dc.identifier.pubmed33360228en_US
bordeaux.journalSeminars in Arthritis and Rheumatismen_US
bordeaux.page36-42en_US
bordeaux.volume51en_US
bordeaux.hal.laboratoriesImmunoConcEpT - UMR 5164en_US
bordeaux.issue1en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionCNRSen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.exportfalse
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft.jtitle=Seminars%20in%20Arthritis%20and%20Rheumatism&amp;rft.date=2021-02&amp;rft.volume=51&amp;rft.issue=1&amp;rft.spage=36-42&amp;rft.epage=36-42&amp;rft.eissn=0049-0172&amp;rft.issn=0049-0172&amp;rft.au=SCHERLINGER,%20Marc&amp;LUTZ,%20J.&amp;GALLI,%20Gael&amp;RICHEZ,%20Christophe&amp;GOTTENBERG,%20J.-E.&amp;rft.genre=article


Archivos en el ítem

ArchivosTamañoFormatoVer

No hay archivos asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem